
Science Meeting Calendar
January 13 - Canceled
​
January 27
​
February 10
Gene Ables, Ph.D.
​
February 24
​
March 10
J. Ignacio Gutiérrez, Ph.D.
Weill Cornell Medicine
​
March 24
Sailendra Nichenametla, Ph.D.
​
April 7
Peter Arvan, MD, Ph.D.
University of Michigan Medical School
​
April 21
Arturo Hernandez, Ph.D.
MaineHealth Institute for Research
​
May 5
Christopher Hine, Ph.D.
​Cleveland Clinic Lerner Research Institute
​
May 19
Jay Johnson, Ph.D.
​
June 9
Dwight Mattocks
​
June 23
Diana Cooke
​
July 14
Basavaraju Sanganahalli, Ph.D.
Yale School of Medicine
​
July 28
Souvik Ghosh, BTech
University of Pittsburgh
​
August - NO MEETINGS
​
September 8
​
September 22
Jason Plummer
​
October 6
​
October 20
​
November 3
​​
November 17
December 8
Gene Ables, Ph.D.
Jay Johnson, Ph.D.
Sailendra Nichenametla, Ph.D.
Year-end Reports
​
​
​

Our Founder
Dr. Norman Orentreich
1922 -2019
Norman Orentreich received his MD degree from New York University College of Medicine in 1948. He became a diplomate of the National Board of Medical Examiners in 1949 and American Board of Dermatology in 1953. During his post-graduate training at New York University’s Skin and Cancer hospital, Dr. Orentreich pioneered the research, creation, and performance of the very first hair transplant to treat male pattern baldness.
​
After having established his dermatology practice (OMG, LLP), he went on to found the biomedical research organization known as the Orentreich Foundation for the Advancement of Science, Inc. (OFAS). In 1968, Dr. Orentreich collaborated with Carol Phillips and the Lauder family to develop the internationally renowned skincare product line, Clinique. In 1970, he became the first President of the American Society for Dermatologic Surgery. Dr. Orentreich created and developed multiple procedures and treatments for skin, hair, and nail maintenance. He invented and patented medicines and medical devices for rejuvenating scarred and aging skin. He also wrote hundreds of articles and book chapters for medical textbooks and journals.
​
Under Dr. Orentreich’s guidance, research at OFAS expanded to encompass aging, cancer, dermatology, and serum biomarkers, resulting in numerous peer-reviewed publications.
Dr. Orentreich passed away on January 23, 2019; however, his legacy prevails as OFAS continues its dedication to the prevention, suspension, or reversal of those disorders that decrease the quality or length of life.